Frequency Therapeutics Closes $62MM Series C Financing
Congratulations to Frequency Therapeutics! They have announced the close of their $62mm Series C financing to expand research of their...
Jul 24, 2019
Welcome to C2I's newest tenants: SynerK, Inc.
We would like to extend a warm welcome to the newest members of the C2I family. SynerK, Inc. is a biotechnology company engaged in the...
Feb 19, 2019
